Assessment of the proliferation status of glioblastoma cell and tumour tissue after nanoplatinum treatment
Open Access
- 31 May 2017
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (5) , e0178277
Abstract
Glioblastoma is one of the most frequent primary brain tumours of the central nervous system, with a poor survival time. With inefficient chemotherapy, it is urgent to develop new strategies for tumour therapy. The present approach is based on the inhibition of cell proliferation using platinum nanoparticles (NP-Pt). The aim of the study was to evaluate and compare the antiproliferative properties of NP-Pt and cisplatin against U87 and U118 glioma cell lines and U87 tumour tissue. NP-Pt and cisplatin were incubated with U87 and U118 glioma cells or administered directly into glioma tumour tissue. Cell morphology, the level of DNA synthesis, the migration of cells, protein expression levels of proliferating cell nuclear antigen (PCNA) and the level of DNA oxidation in glioma tumours were investigated. The results showed that NP-Pt treatment of U87 and U118 glioma cells decreased the level of DNA synthesis and the migration of cancer cells but also downregulated the level of PCNA protein expression in tumour tissue. Furthermore, NP-Pt caused oxidative DNA damage in tumour tissue to a higher degree than cisplatin. Consequently, NP-Pt can be considered as an effective inhibitor of glioblastoma tumour cell proliferation. However, the mechanism of action and potential side effects need to be elucidated further.Keywords
Funding Information
- NCN (NCN 2013/09/N/NZ9/01895)
This publication has 37 references indexed in Scilit:
- Influence of nanoparticles of platinum on chicken embryo development and brain morphologyDiscover Nano, 2013
- Evaluation of synthesized platinum nanoparticles on the MCF-7 and HepG-2 cancer cell linesInternational Nano Letters, 2013
- Transport properties of two finite armchair graphene nanoribbonsDiscover Nano, 2013
- Repair of cisplatin-induced DNA interstrand crosslinks by a replication-independent pathway involving transcription-coupled repair and translesion synthesisNucleic Acids Research, 2012
- Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomideBMC Cancer, 2011
- Nanoparticles of carbon allotropes inhibit glioblastoma multiforme angiogenesis in ovoInternational Journal of Nanomedicine, 2011
- Glioblastoma multiforme: Molecular characterization and current treatment strategy (Review)Experimental and Therapeutic Medicine, 2011
- Catalytic nanomedicine: A new field in antitumor treatment using supported platinum nanoparticles. In vitro DNA degradation and in vivo tests with C6 animal model on Wistar ratsEuropean Journal of Medicinal Chemistry, 2010
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Recognition and processing of cisplatin- and oxaliplatin-DNA adductsCritical Reviews in Oncology/Hematology, 2005